Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Privia Health Group Inc (NASDAQ: PRVA) closed the day trading at $23.38 down -2.66% from the previous closing price of $24.02. In other words, the price has decreased by -$2.66 from its previous closing price. On the day, 0.65 million shares were traded. PRVA stock price reached its highest trading level at $24.11 during the session, while it also had its lowest trading level at $23.33.
Ratios:
For a better understanding of PRVA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.02. For the most recent quarter (mrq), Quick Ratio is recorded 1.86 and its Current Ratio is at 1.86. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $23.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 10 ’25 when Mehrotra Parth sold 9,640 shares for $24.53 per share. The transaction valued at 236,469 led to the insider holds 489,189 shares of the business.
Mehrotra Parth sold 9,294 shares of PRVA for $221,941 on Mar 11 ’25. The Chief Executive Officer now owns 479,895 shares after completing the transaction at $23.88 per share. On Mar 10 ’25, another insider, Mountcastle David, who serves as the EVP & Chief Financial Officer of the company, sold 2,979 shares for $24.53 each. As a result, the insider received 73,075 and left with 188,178 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2817593856 and an Enterprise Value of 2380303104. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 204.37, and their Forward P/E ratio for the next fiscal year is 69.13. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.62 while its Price-to-Book (P/B) ratio in mrq is 4.43. Its current Enterprise Value per Revenue stands at 1.371 whereas that against EBITDA is 98.157.
Stock Price History:
The Beta on a monthly basis for PRVA is 0.84, which has changed by 0.14945924 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, PRVA has reached a high of $26.04, while it has fallen to a 52-week low of $15.92. The 50-Day Moving Average of the stock is 1.25%, while the 200-Day Moving Average is calculated to be 16.42%.
Shares Statistics:
Over the past 3-months, PRVA traded about 724.89K shares per day on average, while over the past 10 days, PRVA traded about 1078070 shares per day. A total of 120.31M shares are outstanding, with a floating share count of 106.68M. Insiders hold about 11.48% of the company’s shares, while institutions hold 96.09% stake in the company. Shares short for PRVA as of 1740700800 were 4143718 with a Short Ratio of 5.72, compared to 1738281600 on 4919187. Therefore, it implies a Short% of Shares Outstanding of 4143718 and a Short% of Float of 5.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
